{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:24:53Z","timestamp":1793413493584,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T00:00:00Z","timestamp":1619395200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T00:00:00Z","timestamp":1619395200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Japanese Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"crossref","award":["17K09797"],"award-info":[{"award-number":["17K09797"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001700","name":"Japanese Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"crossref","award":["17H04247"],"award-info":[{"award-number":["17H04247"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001700","name":"Japanese Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"crossref","award":["16H06402A01"],"award-info":[{"award-number":["16H06402A01"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Mitochondrial electron transport chain abnormalities have been reported in postmortem pathological specimens of Alzheimer\u2019s disease (AD). However, it remains unclear how amyloid and tau are associated with mitochondrial dysfunction in vivo. The purpose of this study is to assess the local relationships between mitochondrial dysfunction and AD pathophysiology in mild AD using the novel mitochondrial complex I PET imaging agent [\n                      <jats:sup>18<\/jats:sup>\n                      F]BCPP-EF.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Thirty-two amyloid and tau positive mild stage AD dementia patients (mean age\u2009\u00b1\u2009SD: 71.1\u2009\u00b1\u20098.3\u2009years) underwent a series of PET measurements with [\n                      <jats:sup>18<\/jats:sup>\n                      F]BCPP-EF mitochondrial function, [\n                      <jats:sup>11<\/jats:sup>\n                      C]PBB3 for tau deposition, and [\n                      <jats:sup>11<\/jats:sup>\n                      C] PiB for amyloid deposition. Age-matched normal control subjects were also recruited. Inter and intrasubject comparisons of levels of mitochondrial complex I activity, amyloid and tau deposition were performed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The [\n                      <jats:sup>18<\/jats:sup>\n                      F]BCPP-EF uptake was significantly lower in the medial temporal area, highlighting the importance of the mitochondrial involvement in AD pathology. [\n                      <jats:sup>11<\/jats:sup>\n                      C]PBB3 uptake was greater in the temporo-parietal regions in AD. Region of interest analysis in the Braak stage I-II region showed significant negative correlation between [\n                      <jats:sup>18<\/jats:sup>\n                      F]BCPP-EF SUVR and [\n                      <jats:sup>11<\/jats:sup>\n                      C]PBB3 BP\n                      <jats:sub>ND<\/jats:sub>\n                      (R\u2009=\u20090.2679,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.04), but not [\n                      <jats:sup>11<\/jats:sup>\n                      C] PiB SUVR.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Our results indicated that mitochondrial complex I is closely associated with tau load evaluated by [\n                      <jats:sup>11<\/jats:sup>\n                      C]PBB3, which might suffer in the presence of its off-target binding. The absence of association between mitochondrial complex I dysfunction with amyloid load suggests that mitochondrial dysfunction in the trans-entorhinal and entorhinal region is a reflection of neuronal injury occurring in the brain of mild AD.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13024-021-00448-1","type":"journal-article","created":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T05:07:22Z","timestamp":1619413642000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":78,"title":["Mitochondrial complex I abnormalities is associated with tau and clinical symptoms in mild Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"16","author":[{"given":"Tatsuhiro","family":"Terada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Therriault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Su Peter","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Savard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tharick Ali","family":"Pascoal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firoza","family":"Lussier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile","family":"Tissot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Benedet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Matsudaira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyasu","family":"Bunai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomokazu","family":"Obi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Tsukada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuomi","family":"Ouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Rosa-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,26]]},"reference":[{"key":"448_CR1","doi-asserted-by":"publisher","unstructured":"Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA research framework: toward a biological definition of Alzheimer's disease. Alzheimers Dement. 2018;14(4):535\u201362. https:\/\/doi.org\/10.1016\/j.jalz.2018.02.018.","DOI":"10.1016\/j.jalz.2018.02.018"},{"key":"448_CR2","doi-asserted-by":"publisher","first-page":"104469","DOI":"10.1016\/j.neuint.2019.104469","volume":"129","author":"S Lautrup","year":"2019","unstructured":"Lautrup S, Lou G, Aman Y, Nilsen H, Tao J, Fang EF. Microglial mitophagy mitigates neuroinflammation in Alzheimer's disease. Neurochem Int. 2019;129:104469. https:\/\/doi.org\/10.1016\/j.neuint.2019.104469.","journal-title":"Neurochem Int"},{"issue":"5","key":"448_CR3","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3892\/br.2016.630","volume":"4","author":"WJ Huang","year":"2016","unstructured":"Huang WJ, Zhang X, Chen WW. Role of oxidative stress in Alzheimer's disease. Biomed Rep. 2016;4(5):519\u201322. https:\/\/doi.org\/10.3892\/br.2016.630.","journal-title":"Biomed Rep"},{"issue":"3","key":"448_CR4","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.3233\/JAD-170585","volume":"62","author":"RH Swerdlow","year":"2018","unstructured":"Swerdlow RH. Mitochondria and mitochondrial cascades in Alzheimer's disease. J Alzheimers Dis. 2018;62(3):1403\u201316. https:\/\/doi.org\/10.3233\/JAD-170585.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"448_CR5","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13024-020-00376-6","volume":"15","author":"W Wang","year":"2020","unstructured":"Wang W, Zhao F, Ma X, Perry G, Zhu X. Mitochondria dysfunction in the pathogenesis of Alzheimer's disease: recent advances. Mol Neurodegener. 2020;15(1):30. https:\/\/doi.org\/10.1186\/s13024-020-00376-6.","journal-title":"Mol Neurodegener"},{"key":"448_CR6","doi-asserted-by":"publisher","first-page":"509654","DOI":"10.1155\/2015\/509654","volume":"2015","author":"FA Cabezas-Opazo","year":"2015","unstructured":"Cabezas-Opazo FA, Vergara-Pulgar K, Perez MJ, Jara C, Osorio-Fuentealba C, Quintanilla RA. Mitochondrial dysfunction contributes to the pathogenesis of Alzheimer's disease. Oxidative Med Cell Longev. 2015;2015:509654.","journal-title":"Oxidative Med Cell Longev"},{"key":"448_CR7","doi-asserted-by":"publisher","unstructured":"Terada T, Obi T, Bunai T, Matsudaira T, Yoshikawa E, Ando I, et al. In vivo mitochondrial and glycolytic impairments in patients with Alzheimer disease. Neurology. 2020;94(15):e1592\u2013e604. https:\/\/doi.org\/10.1212\/WNL.0000000000009249.","DOI":"10.1212\/WNL.0000000000009249"},{"issue":"5054","key":"448_CR8","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy JA, Higgins GA. Alzheimer's disease: the amyloid cascade hypothesis. Science. 1992;256(5054):184\u20135. https:\/\/doi.org\/10.1126\/science.1566067.","journal-title":"Science."},{"key":"448_CR9","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3389\/fnins.2018.00441","volume":"12","author":"MJ Perez","year":"2018","unstructured":"Perez MJ, Jara C, Quintanilla RA. Contribution of tau pathology to mitochondrial impairment in Neurodegeneration. Front Neurosci. 2018;12:441. https:\/\/doi.org\/10.3389\/fnins.2018.00441.","journal-title":"Front Neurosci"},{"key":"448_CR10","first-page":"1240","volume":"2014","author":"X Wang","year":"1842","unstructured":"Wang X, Wang W, Li L, Perry G, Lee HG, Zhu X. Oxidative stress and mitochondrial dysfunction in Alzheimer's disease. Biochim Biophys Acta. 1842;2014:1240\u20137.","journal-title":"Biochim Biophys Acta"},{"key":"448_CR11","first-page":"352723","volume":"2015","author":"Z Liu","year":"2015","unstructured":"Liu Z, Li T, Li P, Wei N, Zhao Z, Liang H, et al. The ambiguous relationship of oxidative stress, tau hyperphosphorylation, and autophagy dysfunction in Alzheimer's disease. Oxidative Med Cell Longev. 2015;2015:352723.","journal-title":"Oxidative Med Cell Longev"},{"key":"448_CR12","doi-asserted-by":"crossref","unstructured":"Barron AM, Ji B, Fujinaga M, Zhang M-R, Suhara T, Sahara N, et al. In vivo PET imaging of mitochondrial abnormalities in a mouse model of tauopathy. Neurobiol Aging. 2020;94:140\u20138.","DOI":"10.1016\/j.neurobiolaging.2020.05.003"},{"issue":"11","key":"448_CR13","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/jlcr.3056","volume":"56","author":"N Harada","year":"2013","unstructured":"Harada N, Nishiyama S, Kanazawa M, Tsukada H. Development of novel PET probes, [18F]BCPP-EF, [18F]BCPP-BF, and [11C]BCPP-EM for mitochondrial complex 1 imaging in the living brain. J Labelled Comp Radiopharm. 2013;56(11):553\u201361. https:\/\/doi.org\/10.1002\/jlcr.3056.","journal-title":"J Labelled Comp Radiopharm"},{"issue":"1","key":"448_CR14","doi-asserted-by":"publisher","first-page":"e0170911","DOI":"10.1371\/journal.pone.0170911","volume":"12","author":"C Murayama","year":"2017","unstructured":"Murayama C, Kawaguchi AT, Kamijo A, Naito K, Kanazawa M, Tsukada H. Monitoring mitochondrial complex-I activity using novel PET probe 18F-BCPP-EF allows early detection of radiotherapy effect in murine squamous cell carcinoma. PLoS One. 2017;12(1):e0170911. https:\/\/doi.org\/10.1371\/journal.pone.0170911.","journal-title":"PLoS One"},{"issue":"11","key":"448_CR15","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1007\/s00259-014-2821-8","volume":"41","author":"H Tsukada","year":"2014","unstructured":"Tsukada H, Nishiyama S, Ohba H, Kanazawa M, Kakiuchi T, Harada N. Comparing amyloid-beta deposition, neuroinflammation, glucose metabolism, and mitochondrial complex I activity in brain: a PET study in aged monkeys. Eur J Nucl Med Mol Imaging. 2014;41(11):2127\u201336. https:\/\/doi.org\/10.1007\/s00259-014-2821-8.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"448_CR16","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1192\/bjp.140.6.566","volume":"140","author":"CP Hughes","year":"1982","unstructured":"Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry. 1982;140(6):566\u201372. https:\/\/doi.org\/10.1192\/bjp.140.6.566.","journal-title":"Br J Psychiatry"},{"key":"448_CR17","doi-asserted-by":"publisher","unstructured":"Ahn YD, Yi D, Joung H, Seo EH, Lee YH, Byun MS, et al. Normative data for the logical memory subtest of the Wechsler memory scale-IV in middle-aged and elderly Korean people. Psychiatry Investig. 2019;16(11):793\u20139. https:\/\/doi.org\/10.30773\/pi.2019.0061.","DOI":"10.30773\/pi.2019.0061"},{"issue":"3","key":"448_CR18","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7(3):263\u20139. https:\/\/doi.org\/10.1016\/j.jalz.2011.03.005.","journal-title":"Alzheimers Dement"},{"issue":"4","key":"448_CR19","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/jcbfm.1992.81","volume":"12","author":"HW Muller-Gartner","year":"1992","unstructured":"Muller-Gartner HW, Links JM, Prince JL, Bryan RN, McVeigh E, Leal JP, et al. Measurement of radiotracer concentration in brain gray matter using positron emission tomography: MRI-based correction for partial volume effects. J Cereb Blood Flow Metab. 1992;12(4):571\u201383. https:\/\/doi.org\/10.1038\/jcbfm.1992.81.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"448_CR20","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2466\/pr0.1988.62.1.259","volume":"62","author":"CB Holmes","year":"1988","unstructured":"Holmes CB, Fouty HE, Wurtz PJ, Burdick BM. Zung self-rating depression scale scores of psychiatric outpatients by age and sex. Psychol Rep. 1988;62(1):259\u201362. https:\/\/doi.org\/10.2466\/pr0.1988.62.1.259.","journal-title":"Psychol Rep"},{"issue":"12","key":"448_CR21","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","volume":"44","author":"JL Cummings","year":"1994","unstructured":"Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44(12):2308\u201314. https:\/\/doi.org\/10.1212\/WNL.44.12.2308.","journal-title":"Neurology."},{"issue":"9","key":"448_CR22","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/j.1532-5415.1992.tb01992.x","volume":"40","author":"TN Tombaugh","year":"1992","unstructured":"Tombaugh TN, McIntyre NJ. The mini-mental state examination: a comprehensive review. J Am Geriatr Soc. 1992;40(9):922\u201335. https:\/\/doi.org\/10.1111\/j.1532-5415.1992.tb01992.x.","journal-title":"J Am Geriatr Soc"},{"key":"448_CR23","doi-asserted-by":"publisher","unstructured":"Terada T, Yokokura M, Obi T, Bunai T, Yoshikawa E, Ando I, et al. In vivo direct relation of tau pathology with neuroinflammation in early Alzheimer's disease. J Neurol. 2019;266(9):2186\u201396. https:\/\/doi.org\/10.1007\/s00415-019-09400-2.","DOI":"10.1007\/s00415-019-09400-2"},{"key":"448_CR24","doi-asserted-by":"publisher","unstructured":"Kantarci K, Lowe VJ, Boeve BF, Senjem ML, Tosakulwong N, Lesnick TG, et al. AV-1451 tau and beta-amyloid positron emission tomography imaging in dementia with Lewy bodies. Ann Neurol. 2017;81(1):58\u201367. https:\/\/doi.org\/10.1002\/ana.24825.","DOI":"10.1002\/ana.24825"},{"key":"448_CR25","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3389\/fninf.2016.00020","volume":"10","author":"S Mathotaarachchi","year":"2016","unstructured":"Mathotaarachchi S, Wang S, Shin M, Pascoal TA, Benedet AL, Kang MS, et al. VoxelStats: a MATLAB package for multi-modal voxel-wise brain image analysis. Front Neuroinform. 2016;10:20.","journal-title":"Front Neuroinform"},{"key":"448_CR26","doi-asserted-by":"publisher","unstructured":"Therriault J, Ng KP, Pascoal TA, Mathotaarachchi S, Kang MS, Struyfs H, et al. Anosognosia predicts default mode network hypometabolism and clinical progression to dementia. Neurology. 2018;90(11):e932\u2013e9. https:\/\/doi.org\/10.1212\/WNL.0000000000005120.","DOI":"10.1212\/WNL.0000000000005120"},{"issue":"4","key":"448_CR27","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82(4):239\u201359. https:\/\/doi.org\/10.1007\/BF00308809.","journal-title":"Acta Neuropathol"},{"issue":"5","key":"448_CR28","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.neuron.2016.01.028","volume":"89","author":"M Scholl","year":"2016","unstructured":"Scholl M, Lockhart SN, Schonhaut DR, O'Neil JP, Janabi M, Ossenkoppele R, et al. PET imaging of tau deposition in the aging human brain. Neuron. 2016;89(5):971\u201382. https:\/\/doi.org\/10.1016\/j.neuron.2016.01.028.","journal-title":"Neuron."},{"key":"448_CR29","doi-asserted-by":"publisher","unstructured":"Johnson KA, Schultz A, Betensky RA, Becker JA, Sepulcre J, Rentz D, et al. Tau positron emission tomographic imaging in aging and early Alzheimer disease. Ann Neurol. 2016;79(1):110\u20139. https:\/\/doi.org\/10.1002\/ana.24546.","DOI":"10.1002\/ana.24546"},{"key":"448_CR30","doi-asserted-by":"publisher","unstructured":"Pascoal TA, Therriault J, Benedet AL, Savard M, Lussier FZ, Chamoun M, et al. 18F-MK-6240 PET for early and late detection of neurofibrillary tangles. Brain. 2020;143(9):2818\u201330. https:\/\/doi.org\/10.1093\/brain\/awaa180.","DOI":"10.1093\/brain\/awaa180"},{"key":"448_CR31","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1038\/s41467-019-09564-5","volume":"10","author":"N Franzmeier","year":"2019","unstructured":"Franzmeier N, Rubinski A, Neitzel J, Ewers M. Alzheimer's Disease Neuroimaging I. The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory. Nat Commun. 2019;10:1766.","journal-title":"Nat Commun"},{"issue":"5","key":"448_CR32","doi-asserted-by":"publisher","first-page":"e388","DOI":"10.1212\/WNL.0000000000004887","volume":"90","author":"N Mattsson","year":"2018","unstructured":"Mattsson N, Smith R, Strandberg O, Palmqvist S, Scholl M, Insel PS, et al. Comparing (18) F-AV-1451 with CSF t-tau and p-tau for diagnosis of Alzheimer disease. Neurology. 2018;90(5):e388\u2013e95. https:\/\/doi.org\/10.1212\/WNL.0000000000004887.","journal-title":"Neurology."},{"key":"448_CR33","doi-asserted-by":"publisher","first-page":"a006189","DOI":"10.1101\/cshperspect.a006189","volume":"1","author":"A Serrano-Pozo","year":"2011","unstructured":"Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT. Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med. 2011;1:a006189.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"Suppl 2","key":"448_CR34","doi-asserted-by":"publisher","first-page":"S369","DOI":"10.3233\/JAD-2010-100543","volume":"20","author":"M Di Filippo","year":"2010","unstructured":"Di Filippo M, Chiasserini D, Tozzi A, Picconi B, Calabresi P. Mitochondria and the link between neuroinflammation and neurodegeneration. J Alzheimers Dis. 2010;20(Suppl 2):S369\u201379. https:\/\/doi.org\/10.3233\/JAD-2010-100543.","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"448_CR35","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.neurobiolaging.2003.09.009","volume":"25","author":"B Schonheit","year":"2004","unstructured":"Schonheit B, Zarski R, Ohm TG. Spatial and temporal relationships between plaques and tangles in Alzheimer-pathology. Neurobiol Aging. 2004;25(6):697\u2013711. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2003.09.009.","journal-title":"Neurobiol Aging"},{"key":"448_CR36","doi-asserted-by":"publisher","unstructured":"Chapman KR, Bing-Canar H, Alosco ML, Steinberg EG, Martin B, Chaisson C, et al. Mini mental state examination and logical memory scores for entry into Alzheimer's disease trials. Alzheimers Res Ther. 2016;8(1):9. https:\/\/doi.org\/10.1186\/s13195-016-0176-z.","DOI":"10.1186\/s13195-016-0176-z"},{"key":"448_CR37","first-page":"936272","volume":"2012","author":"I Reinvang","year":"2012","unstructured":"Reinvang I, Grambaite R, Espeseth T. Executive dysfunction in MCI: subtype or early symptom. Int J Alzheimers Dis. 2012;2012:936272.","journal-title":"Int J Alzheimers Dis"},{"issue":"11","key":"448_CR38","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1212\/WNL.55.11.1621","volume":"55","author":"B Dubois","year":"2000","unstructured":"Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a frontal assessment battery at bedside. Neurology. 2000;55(11):1621\u20136. https:\/\/doi.org\/10.1212\/WNL.55.11.1621.","journal-title":"Neurology."},{"key":"448_CR39","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3389\/fncel.2018.00114","volume":"12","author":"H Solleiro-Villavicencio","year":"2018","unstructured":"Solleiro-Villavicencio H, Rivas-Arancibia S. Effect of chronic oxidative stress on Neuroinflammatory response mediated by CD4(+)T cells in neurodegenerative diseases. Front Cell Neurosci. 2018;12:114. https:\/\/doi.org\/10.3389\/fncel.2018.00114.","journal-title":"Front Cell Neurosci"},{"issue":"3-4","key":"448_CR40","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/biof.5520080305","volume":"8","author":"G Lenaz","year":"1998","unstructured":"Lenaz G, Cavazzoni M, Genova ML, D'Aurelio M, Merlo Pich M, Pallotti F, et al. Oxidative stress, antioxidant defences and aging. Biofactors. 1998;8(3-4):195\u2013204. https:\/\/doi.org\/10.1002\/biof.5520080305.","journal-title":"Biofactors."},{"issue":"2","key":"448_CR41","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0005-2728(98)00033-4","volume":"1364","author":"BH Robinson","year":"1998","unstructured":"Robinson BH. Human complex I deficiency: clinical spectrum and involvement of oxygen free radicals in the pathogenicity of the defect. Biochim Biophys Acta. 1998;1364(2):271\u201386. https:\/\/doi.org\/10.1016\/S0005-2728(98)00033-4.","journal-title":"Biochim Biophys Acta"},{"key":"448_CR42","doi-asserted-by":"crossref","first-page":"305395","DOI":"10.4061\/2011\/305395","volume":"2011","author":"SJ Baloyannis","year":"2011","unstructured":"Baloyannis SJ. Mitochondria are related to synaptic pathology in Alzheimer's disease. Int J Alzheimers Dis. 2011;2011:305395.","journal-title":"Int J Alzheimers Dis"},{"key":"448_CR43","doi-asserted-by":"publisher","unstructured":"Chiotis K, Stenkrona P, Almkvist O, Stepanov V, Ferreira D, Arakawa R, et al. Dual tracer tau PET imaging reveals different molecular targets for (11) C-THK5351 and (11) C-PBB3 in the Alzheimer brain. Eur J Nucl Med Mol Imaging. 2018;45(9):1605\u201317. https:\/\/doi.org\/10.1007\/s00259-018-4012-5.","DOI":"10.1007\/s00259-018-4012-5"},{"key":"448_CR44","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.dadm.2018.01.007","volume":"10","author":"L Lemoine","year":"2018","unstructured":"Lemoine L, Leuzy A, Chiotis K, Rodriguez-Vieitez E, Nordberg A. Tau positron emission tomography imaging in tauopathies: The added hurdle of off-target binding. Alzheimers Dement (Amst). 2018;10:232\u20136.","journal-title":"Alzheimers Dement (Amst)"},{"key":"448_CR45","doi-asserted-by":"publisher","unstructured":"Leuzy A, Cicognola C, Chiotis K, Saint-Aubert L, Lemoine L, Andreasen N, et al. Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer's disease. Eur J Nucl Med Mol Imaging. 2019;46(5):1152\u201363. https:\/\/doi.org\/10.1007\/s00259-018-4242-6.","DOI":"10.1007\/s00259-018-4242-6"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-021-00448-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-021-00448-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-021-00448-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T07:37:10Z","timestamp":1724917030000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularneurodegeneration.biomedcentral.com\/articles\/10.1186\/s13024-021-00448-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,26]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["448"],"URL":"https:\/\/doi.org\/10.1186\/s13024-021-00448-1","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,26]]},"assertion":[{"value":"29 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was reviewed and approved by the ethics committee of Shizuoka Institute of Epilepsy and Neurological Disorders (SIEND), Hamamatsu University School of Medicine, and Hamamatsu Medical Center. Written informed consent was obtained from all subjects to participate in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28"}}